G

GeneSystem Co Ltd
KOSDAQ:363250

Watchlist Manager
GeneSystem Co Ltd
KOSDAQ:363250
Watchlist
Price: 5 030 KRW -7.54% Market Closed
Market Cap: ₩35.4B

Net Margin

-2 589.3%
Current
Declining
by 1 643.8%
vs 3-y average of -945.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2 589.3%
=
Net Income
₩-8.9B
/
Revenue
₩345.4m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2 589.3%
=
Net Income
₩-8.9B
/
Revenue
₩345.4m

Peer Comparison

Country Company Market Cap Net
Margin
KR
GeneSystem Co Ltd
KOSDAQ:363250
34.3B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
391.7B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
173.2B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.9B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.9B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Lower than 99% of companies in Korea
Percentile
1st
Based on 2 632 companies
1st percentile
-2 589.3%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

GeneSystem Co Ltd
Glance View

Market Cap
35.4B KRW
Industry
Biotechnology

Genesystem Co., Ltd engages in providing PCR based molecular diagnostic products. The firm is engaged in the development, manufacture and sale of platform based on molecular diagnosis. The firm develops and manufactures products such as molecular diagnosis systems, biochips, test kits, and reaction reagents, among others. The firm develops in vitro diagnostic technology through immunodiagnosis technology and molecular diagnosis technology.

Intrinsic Value
1 509.09 KRW
Overvaluation 70%
Intrinsic Value
Price
G
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-2 589.3%
=
Net Income
₩-8.9B
/
Revenue
₩345.4m
What is GeneSystem Co Ltd's current Net Margin?

The current Net Margin for GeneSystem Co Ltd is -2 589.3%, which is below its 3-year median of -945.5%.

How has Net Margin changed over time?

Over the last 3 years, GeneSystem Co Ltd’s Net Margin has decreased from -38.6% to -2 589.3%. During this period, it reached a low of -2 589.3% on Sep 30, 2025 and a high of -38.6% on Sep 30, 2022.

Back to Top